YWHAQ and neurodegenerative disease: The transformation of the neurodestructive dystrophic microglial structures to a neuroprotective structural configuration, as well as a reduction in the CSF concentration of tau-proteins, which are proteins implicated in the pathogenesis of many neurodegenerative diseases, may suggest that VNS could potentially be used in the treatment of neurodegenerative conditions.